Literature DB >> 12738673

Functional comparison of DCs generated in vivo with Flt3 ligand or in vitro from blood monocytes: differential regulation of function by specific classes of physiologic stimuli.

Michael Jefford1, Max Schnurr, Tracey Toy, Kelly-Anne Masterman, Amanda Shin, Tina Beecroft, Tsin Yee Tai, Ken Shortman, Mark Shackleton, Ian D Davis, Phil Parente, Thomas Luft, Weisan Chen, Jonathan Cebon, Eugene Maraskovsky.   

Abstract

Dendritic cells (DCs) are a family of leukocytes that initiate T- and B-cell immunity against pathogens. Migration of antigen-loaded DCs from sites of infection into draining lymphoid tissues is fundamental to the priming of T-cell immune responses. In humans, the major peripheral blood DC (PBDC) types, CD1c+ DCs and interleukin 3 receptor-positive (IL-3R+) plasmacytoid DCs, are significantly expanded in vivo with the use of Flt3 ligand (FL). DC-like cells can also be generated from monocyte precursors (MoDCs). A detailed comparison of the functional potential of these types of DCs (in an autologous setting) has yet to be reported. Here, we compared the functional capacity of FL-expanded CD1c+ PBDCs with autologous MoDCs in response to 3 different classes of stimuli: (1) proinflammatory mediators, (2) soluble CD40 ligand trimer (CD40L), and (3) intact bacteria (Escherichia coli). Significant differences in functional capacities were found with respect to changes in phenotype, migratory capacity, cytokine secretion, and T-cell stimulation. MoDCs required specific stimuli for the expression of functions. They responded vigorously to CD40L or E coli, expressing cytokines known to regulate interferon-gamma (IFN-gamma) in T cells (IL-12p70, IL-18, and IL-23), but required prostaglandin E2 (PGE2) during stimulation to migrate to chemokines. In contrast, PBDCs matured in response to minimal stimulation, rapidly acquired migratory function in the absence of PGE2-containing stimuli, and were low cytokine producers. Interestingly, both types of DCs were equivalent with respect to stimulation of allogeneic T-cell proliferation and presentation of peptides to cytotoxic T lymphocyte (CTL) lines. These distinct differences are of particular importance when considering the choice of DC types for clinical applications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738673     DOI: 10.1182/blood-2002-12-3854

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  30 in total

1.  DC maturation and function are not altered by melanoma-derived immunosuppressive soluble factors.

Authors:  Joel M Baumgartner; Kimberly R Jordan; Ling-Jia Hu; Cara C Wilson; Anirban Banerjee; Martin D McCarter
Journal:  J Surg Res       Date:  2011-08-24       Impact factor: 2.192

Review 2.  Toll-like receptor-independent triggering of dendritic cell maturation by viruses.

Authors:  Carolina B López; Jacob S Yount; Thomas M Moran
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

3.  Generation of bone marrow derived murine dendritic cells for use in 2-photon imaging.

Authors:  Melanie P Matheu; Debasish Sen; Michael D Cahalan; Ian Parker
Journal:  J Vis Exp       Date:  2008-07-09       Impact factor: 1.355

4.  Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells.

Authors:  Anna Smed-Sörensen; Karin Loré; Jayanand Vasudevan; Mark K Louder; Jan Andersson; John R Mascola; Anna-Lena Spetz; Richard A Koup
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes.

Authors:  Wen Jing Sim; Frano Malinarich; Anna-Marie Fairhurst; John Edward Connolly
Journal:  J Vis Exp       Date:  2016-06-22       Impact factor: 1.355

Review 6.  Dendritic-cell interactions with HIV: infection and viral dissemination.

Authors:  Li Wu; Vineet N KewalRamani
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

7.  CMRF-56(+) blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses.

Authors:  Phillip D Fromm; Michael S Papadimitrious; Jennifer L Hsu; Nicolas Van Kooten Losio; Nirupama D Verma; Tsun Ho Lo; Pablo A Silveira; Christian E Bryant; Cameron J Turtle; Rebecca L Prue; Peter Vukovic; David J Munster; Tomoko Nagasaki; Ross T Barnard; Stephen M Mahler; Sébastien A Anguille; Zwi Berneman; Lisa G Horvath; Kenneth F Bradstock; Douglas E Joshua; Georgina J Clark; Derek N J Hart
Journal:  Oncoimmunology       Date:  2016-05-05       Impact factor: 8.110

8.  Inhibition of dendritic cell maturation by malaria is dose dependent and does not require Plasmodium falciparum erythrocyte membrane protein 1.

Authors:  Salenna R Elliott; Timothy P Spurck; Joelle M Dodin; Alexander G Maier; Till S Voss; Francisca Yosaatmadja; Paul D Payne; Geoffrey I McFadden; Alan F Cowman; Stephen J Rogerson; Louis Schofield; Graham V Brown
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

9.  HIV gag protein is efficiently cross-presented when targeted with an antibody towards the DEC-205 receptor in Flt3 ligand-mobilized murine DC.

Authors:  Leonia Bozzacco; Christine Trumpfheller; Yaoxing Huang; Maria Paula Longhi; Irina Shimeliovich; Joseph D Schauer; Chae Gyu Park; Ralph M Steinman
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

10.  Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.

Authors:  Sarah L Jongbloed; Andrew J Kassianos; Kylie J McDonald; Georgina J Clark; Xinsheng Ju; Catherine E Angel; Chun-Jen J Chen; P Rod Dunbar; Robert B Wadley; Varinder Jeet; Annelie J E Vulink; Derek N J Hart; Kristen J Radford
Journal:  J Exp Med       Date:  2010-05-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.